Cathie Wood’s Latest Portfolio: 5 New Stock Picks

Page 1 of 5

In this article, we discuss the 5 new stocks that Cathie Wood added to her portfolio in Q4 2021. If you want to read our comprehensive analysis of  ARK Investment Management’s investment strategy, go directly to Cathie Wood’s Latest Portfolio: 10 New Stock Picks.

5. Burning Rock Biotech Limited (NASDAQ:BNR)

ARK Investment Management’s Stake Value: $8.07 million

Percentage of ARK Investment Management’s 13F Portfolio: 0.02%

Number of Hedge Fund Holders: 11

Burning Rock Biotech Limited (NASDAQ:BNR) is a Chinese biopharmaceutical firm that offers cancer diagnostic tests for a range of cancer types and operates through the segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. Cathie Wood added the firm’s stock to her portfolio over the fourth quarter, with roughly 848,000 shares worth $8.07 million, representing 0.02% of her overall portfolio.

Investors were bullish on Burning Rock Biotech Limited (NASDAQ:BNR) at the close of the third quarter, with 11 hedge funds holding positions with a combined value of $52.5 million. This is in comparison to 9 hedge funds with $81.7 million worth of holdings in Burning Rock Biotech Limited (NASDAQ:BNR) in Q2 2021.

In December, Burning Rock Biotech Limited (NASDAQ:BNR) announced that it expects its revenue for 2021 to be around RMB500 million, or ‘slightly above’. Although Covid restrictions hampered overall growth, in-hospital testing volumes have grown, and central-lab testing volumes also recorded improvements, underpinned by a positive market response to two products: DetermaRx and myChoice.


Page 1 of 5